ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.61
+0.13 (1.37%)
Nov 5, 2024, 3:54 PM EST - Market open

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
6765022655791,240-
Upgrade
Market Cap Growth
36.22%89.55%-54.26%-53.32%--
Upgrade
Enterprise Value
392285843021,053-
Upgrade
Last Close Price
9.489.205.8914.7033.85-
Upgrade
PE Ratio
--4.70-2.62-7.09-10.08-
Upgrade
PB Ratio
2.122.241.192.124.28-
Upgrade
P/FCF Ratio
-4.75-5.80-3.43-9.57-27.00-
Upgrade
P/OCF Ratio
-4.78-5.86-3.52-9.72-27.39-
Upgrade
EV/EBITDA Ratio
-1.37-2.60-0.97-3.87-21.78-
Upgrade
EV/EBIT Ratio
-1.36-2.58-0.96-3.83-21.35-
Upgrade
EV/FCF Ratio
-1.69-3.30-1.08-4.99-22.93-
Upgrade
Debt / Equity Ratio
0.030.050.050.05--
Upgrade
Debt / FCF Ratio
-0.10-0.12-0.16-0.21--
Upgrade
Quick Ratio
14.6610.1813.4015.6432.6116.65
Upgrade
Current Ratio
15.0810.3913.6815.8732.9616.81
Upgrade
Return on Equity (ROE)
-38.79%-45.11%-35.99%-27.98%-39.02%-41.10%
Upgrade
Return on Assets (ROA)
-25.20%-27.74%-19.87%-16.50%-15.69%-25.36%
Upgrade
Return on Capital (ROIC)
-26.41%-29.54%-20.86%-17.14%-16.33%-27.30%
Upgrade
Earnings Yield
-16.57%-20.06%-33.66%-13.60%-5.94%-
Upgrade
FCF Yield
-15.01%-17.24%-29.16%-10.45%-3.70%-
Upgrade
Buyback Yield / Dilution
-48.28%-29.75%-4.48%-72.97%-1055.26%-9.53%
Upgrade
Total Shareholder Return
-48.28%-29.75%-4.48%-72.97%-1055.26%-9.53%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.